Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.0950 (-5.3%) ($5.0950 - $5.0950) on Mon. Apr. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.48% (three month average) | RSI | 42 | Latest Price | $5.0950(-5.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -1.5% a day on average for past five trading days. | Weekly Trend | ANPC declines -3.9% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) URA(22%) IGOV(16%) BLOK(15%) REMX(15%) XME(15%) | Factors Impacting ANPC price | ANPC will decline at least -4.24% in a week (0% probabilities). SHY(-28%) CEMB(-22%) UNG(-13%) VCSH(-9%) XLC(-8%) | | | | | Relative Volatility | | | | Market Trend Strength | -4.24% (StdDev 8.48%) | Hourly BBV | -0.9 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-6.94(-236.21%) | Resistance Level | $5.84 | 5 Day Moving Average | $5.42(-6%) | 10 Day Moving Average | $5.58(-8.69%) | 20 Day Moving Average | $5.84(-12.76%) | To recent high | -39.8% | To recent low | 0% | Market Cap | $44m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |